We are trying to understand why ORS/Zinc use to treat childhood diarrhea has been successfully scaledup in some countries, but not in others. We are developing a series of country-specific case studies in order to compare successful scale up programs, such as in Bangladesh where ORS is widely available and used to treat most cases of childhood diarrhea, with countries where ORS is not widely available and/or successful scale-up was not sustained.
We have read publicly available documents, but there are still substantial gaps in our knowledge of the local characteristics of health delivery, the history of ORS and zinc scale up programs, and big picture insights into the conditions that favor ORS/Zinc scale up. We are hoping that you might be able to help us fill in some of those gaps or might suggest additional people to talk to.
Also, to the extent that we still have questions, we hope that you might be able to suggest additional people that we can contact who might be able to provide the information we're looking for.
Probing questions -

Do they understand what we are trying to do and do they have any immediate feedback?
PERSONAL EXPERIENCE QUESTIONS
Please tell us about your background with regards to child health and <country>.
What is your experience with the ORS/Zinc scale up program in <country>? GENERAL QUESTIONS
What is your brief (two-minute) history of ORS in <country>?
2. What were the major drivers of the success/lack of success of ORS scale-up?
3. Who was involved in the delivery of diarrhea control programs? 4. What would it take, in your opinion, to sustain ORS coverage at greater than 60% and to get zinc to reach 25% coverage within the next 10 years in <country>?
5. What are the top factors you believe led to a (un)successful scale-up? Why?
6. Looking back, is there something that you would have changed (or done differently)?
